O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/17/2020ACC: 0001209191-20-024777
Officer· Chief Medical Officer
Since Jun 2018
+82.00
Net shares
Net buyer
$935.62
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
82.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+41.00
Price / share
$22.82
Trade value
$935.62
% of position
2.2%
4/15/2020
1.87K→1.91K
Total
Net shares
+41.00
Net value
$935.62
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2020 | A · Award | +41.00 | $22.82 | $935.62 | 2.2% | 1.87K | 1.91K |
| Total | +41.00 | $935.62 | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
41.00 shares
Shares
+41.00
Strike price
26.85
Held after
41.00
Exercisable
—
4/15/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock41.00 shares | 4/15/2020 | A · Award | +41.00 | 26.85 | — | 41.00 |